201 related articles for article (PubMed ID: 37992061)
41. What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review.
De Vrieze T; Nevelsteen I; Thomis S; De Groef A; Tjalma WAA; Gebruers N; Devoogdt N
Support Care Cancer; 2020 Feb; 28(2):439-449. PubMed ID: 31656987
[TBL] [Abstract][Full Text] [Related]
42. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
[TBL] [Abstract][Full Text] [Related]
43. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.
Oh SH; Ku H; Park KS
BMC Public Health; 2021 Mar; 21(1):548. PubMed ID: 33743612
[TBL] [Abstract][Full Text] [Related]
44. Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease: A Systematic Review and Meta-analysis.
Chadalawada S; Sillau S; Archuleta S; Mundo W; Bandali M; Parra-Henao G; Rodriguez-Morales AJ; Villamil-Gomez WE; Suárez JA; Shapiro L; Hotez PJ; Woc-Colburn L; DeSanto K; Rassi A; Franco-Paredes C; Henao-Martínez AF
JAMA Netw Open; 2020 Aug; 3(8):e2015072. PubMed ID: 32865573
[TBL] [Abstract][Full Text] [Related]
45. A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies.
Wong AW; Koo J; Ryerson CJ; Sadatsafavi M; Chen W
BMC Pulm Med; 2022 Apr; 22(1):148. PubMed ID: 35443657
[TBL] [Abstract][Full Text] [Related]
46. The economic burden of bronchiectasis - known and unknown: a systematic review.
Goeminne PC; Hernandez F; Diel R; Filonenko A; Hughes R; Juelich F; Solomon GM; Upton A; Wichmann K; Xu W; Chalmers JD
BMC Pulm Med; 2019 Feb; 19(1):54. PubMed ID: 30819166
[TBL] [Abstract][Full Text] [Related]
47. Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis.
Iyengar S; Tay-Teo K; Vogler S; Beyer P; Wiktor S; de Joncheere K; Hill S
PLoS Med; 2016 May; 13(5):e1002032. PubMed ID: 27243629
[TBL] [Abstract][Full Text] [Related]
48. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
49. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation.
Nellesen D; Yee K; Chawla A; Lewis BE; Carson RT
J Manag Care Pharm; 2013; 19(9):755-64. PubMed ID: 24156644
[TBL] [Abstract][Full Text] [Related]
50. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia.
Ganasegeran K; Hor CP; Jamil MFA; Loh HC; Noor JM; Hamid NA; Suppiah PD; Abdul Manaf MR; Ch'ng ASH; Looi I
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784771
[TBL] [Abstract][Full Text] [Related]
51. How much is the cost of multiple sclerosis--systematic literature review.
Kolasa K
Przegl Epidemiol; 2013; 67(1):75-9, 157-60. PubMed ID: 23745380
[TBL] [Abstract][Full Text] [Related]
52. How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis.
Kastner RJ; Sicuri E; Stone CM; Matwale G; Onapa A; Tediosi F
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005934. PubMed ID: 28949987
[TBL] [Abstract][Full Text] [Related]
53. Cost of adult chronic rhinosinusitis: A systematic review.
Smith KA; Orlandi RR; Rudmik L
Laryngoscope; 2015 Jul; 125(7):1547-56. PubMed ID: 25640115
[TBL] [Abstract][Full Text] [Related]
54. Economic costs of Chagas disease in Colombia in 2017: A social perspective.
Olivera MJ; Buitrago G
Int J Infect Dis; 2020 Feb; 91():196-201. PubMed ID: 31770619
[TBL] [Abstract][Full Text] [Related]
55. The burden of osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and Argentina.
Aziziyeh R; Amin M; Habib M; Garcia Perlaza J; Szafranski K; McTavish RK; Disher T; Lüdke A; Cameron C
J Med Econ; 2019 Jul; 22(7):638-644. PubMed ID: 30835577
[No Abstract] [Full Text] [Related]
56. Economic burden of respiratory syncytial virus infection in adults: a systematic literature review.
Grace M; Colosia A; Wolowacz S; Panozzo C; Ghaswalla P
J Med Econ; 2023; 26(1):742-759. PubMed ID: 37167068
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and socio-economic burden of heart failure in an aging society of South Korea.
Lee H; Oh SH; Cho H; Cho HJ; Kang HY
BMC Cardiovasc Disord; 2016 Nov; 16(1):215. PubMed ID: 27832754
[TBL] [Abstract][Full Text] [Related]
58. Hospitalizations due to gastrointestinal Chagas disease: National registry.
Bierrenbach AL; Quintino ND; Moreira CHV; Damasceno RF; Nunes MDCP; Baldoni NR; de Oliveira da Silva LC; Ferreira AM; Cardoso CS; Haikal DS; Sabino EC; Ribeiro ALP; Oliveira CDL
PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010796. PubMed ID: 36121897
[TBL] [Abstract][Full Text] [Related]
59. The economic burden of systemic sclerosis-A systematic review.
Chen Y; Wu L; J Hernández-Muñoz J; J Miller M; Pope M; Huyan Y; Zhong L
Int J Rheum Dis; 2022 Feb; 25(2):110-120. PubMed ID: 34970861
[TBL] [Abstract][Full Text] [Related]
60. The direct and indirect costs associated with endometriosis: a systematic literature review.
Soliman AM; Yang H; Du EX; Kelley C; Winkel C
Hum Reprod; 2016 Apr; 31(4):712-22. PubMed ID: 26851604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
